Outcomes and prognosis: latest news

Outcomes and prognosis resources

Outcomes and prognosis features

Outcomes and prognosis in your own words

Outcomes and prognosis news from aidsmap

More news

Outcomes and prognosis news selected from other sources

  • Life expectancy of HIV-positive Canadians rises to 65 years: study

    The study, from the Canadian Observational Cohort Collaboration, indicated the overall life expectancy of Canadians undergoing antiretroviral treatment for the AIDS-causing virus had climbed to 65 years -- about a 16-year jump since 2000.

    10 August 2015 | CTV News
  • People with HIV live almost 20 years longer than in 2001

    People living with the HIV virus today can expect to live nearly two decades longer than those who were diagnosed at the start of this century, thanks to cheaper and more readily available antiretroviral drugs, the UN said in a major report on a disease once seen by many as a death sentence to be endured in secrecy. The average HIV-positive person is now expected to live for 55 years – 19 years longer than in 2001, according to the report by the UN’s Programme on HIV and AIDS (UNAids).

    14 July 2015 | The Guardian
  • UNAIDS announces that the goal of 15 million people on life-saving HIV treatment by 2015 has been met nine months ahead of schedule

    The AIDS targets of MDG 6—halting and reversing the spread of HIV—have been achieved and exceeded, according to a new report released today by the Joint United Nations Programme on HIV/AIDS (UNAIDS). New HIV infections have fallen by 35% and AIDS-related deaths by 41%. The global response to HIV has averted 30 million new HIV infections and nearly 8 million (7.8 million) AIDS-related deaths since 2000, when the MDGs were set.

    14 July 2015 | UNAIDS
  • Long-Term Painkiller Use Linked to Higher Death Risk Among HIV-Positive Individuals

    Long-term opioid use conferred a 40% higher death risk in a prospective study of U.S. veterans with or without HIV. The heightened risk ran to 46% in veterans with HIV compared with 25% in those without HIV. Long-term benzodiazepine use also inflated death risk in this population.

    17 June 2015 | The Body
  • US funding for HIV treatment linked with employment gains in sub-Saharan Africa

    We found that PEPFAR was associated with a 13 percent increase in employment among males in focus nations compared to non-focus ones. In contrast, no change in employment was observed among females. In addition, we found that increasing PEPFAR per capita funding by $100 was associated with a 9.1-percentage-point average increase in employment among males.

    15 June 2015 | Brookings Institution (blog)
  • When to START has never been clearer

    Posirtive Lite editor Bob Leahy in conversation with CATIE’s Sean Hosein about START, the important and ground-breaking study that recently provided definitive evidence of the health benefits of starting HIV treatment sooner rather than later.

    10 June 2015 | Positive Lite
  • Gender difference in vital cell count of HIV patients

    Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research. Researchers also found a link between potential proxy measures of nutritional status and disease progression, with those reporting food shortages and use of nutritional supplements reaching lower levels of immunity faster.

    10 June 2015 | Science Daily
  • AIDS-Opportunistic Illness Mortality Lower but Still a Risk

    Survival after the first diagnosis of AIDS-opportunistic illness (OI) has markedly improved since 1981, but some AIDS-OIs still carry a much higher mortality risk than others, according to a survival analysis published online June 3 in the Journal of Infectious Diseases.

    08 June 2015 | Medscape
  • UNAIDS welcomes further evidence that starting antiretroviral therapy early saves lives

    “Every person living with HIV should have immediate access to life-saving antiretroviral therapy,” said Michel Sidibé, Executive Director of UNAIDS. “Delaying access to HIV treatment under any pretext is denying the right to health.”

    28 May 2015 | UNAIDS
  • i-Base Q&A on the START study results

    On 27 May 2015, early results showed that the early treatment group did better. One of the surprises is that even at very high CD4 counts, treatment reduces the risk of HIV related illnesses.

    28 May 2015 | HIV i-Base
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.